NCT05962164Recruiting
Passive Heat Therapy for People With COPD
The Acute and Chronic Benefits of Passive Heat Therapy for People With COPD
Source: ClinicalTrials.gov · Last updated 4 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath. The patients will then undergo 6-weeks of hot-water footbaths to examine whether the changes to blood-flow lead to improvements in blood pressure and other indicators of heart disease risk.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 30 Jun 2023
- Start date
- 17 Aug 2023
- Primary completion date
- 31 May 2026
- Lead sponsor
- University of British Columbia
- Diseases
- COPD
- NCT number
- NCT05962164
What you commit to
- Study type: Interventional
- Planned participants: 32
- From 17 Aug 2023 to the primary completion date, 31 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Have advanced cardiac or cerebrovascular disease (i.e. a history of heart failure, previous stroke or myocardial infarction)
Other illness
- Have uncontrolled hypertension (\>160/95 mmHg at rest)
Other
- Performing structured exercise training (i.e. pulmonary rehabilitation)
- Have hypotension (\<110/60 mmHg)
- Are taking Beta Blockers
- Regularly (\>1/week) have hot baths (\>30 min) or use a hot tub or sauna.
- Have resting blood pressure \> 150/95 mmHg
- On supplemental oxygen for hypoxemia.
- Musculoskeletal pain that limits their ability to perform stationary cycling.
Who the study is looking for
- Non-smoking individuals
- \>40 years of age
- Stable (exacerbation free for \>6 weeks), moderate-to-severe COPD (post bronchodilator FEV1/FVC \<lower limit of normal and FEV1 z-score \<2.51)
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of British Columbia Coordinator of this site? Confirm its status | Kelowna | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.